July 2026
Largest Health Data & Analytics Public Companies in Australia
Benchmark revenue and EBITDA valuation multiples for public comps like
Echo IQ, Cogstate, BlinkLab, Pathkey.AI and Beamtree.
 | Echo IQ Ltd is an Australian medical technology company focused on improving decision-making in cardiology. Its proprietary EchoSolv platform leverages AI-driven analysis of echocardiographic data to help clinicians detect Aortic Stenosis (AS) and other conditions with greater accuracy and efficiency. The company is focused on expanding its strategic partnerships, progressing regulatory pathways, and completing successful deployments of its technology in the USA healthcare market to establish its position in AI-enabled cardiovascular care. | $1 | +613% | $754M | $746M | 10642.2x | (175.4x) | ||
| Cogstate Ltd is a cognitive science company. The principal activity of the group is the Creation, validation, and commercialisation of digital brain health assessments; and the Design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials, Healthcare, and Administration. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services. | $2 | +55% | $322M | $288M | 5.4x | 17.0x | ||
| BlinkLab Ltd is a company that has the license to commercialize the Licensed IP and has developed a smartphone-based application with an e-platform that serves as a medical device to perform neurometric tests to aid in the diagnosis of ASD, ADHD, schizophrenia, and other neurodevelopmental conditions. The results from the BlinkLab Tests are recorded by smartphone and uploaded to BlinkLab’s confidential and secure online platform where the data is analyzed. | $0 | +6% | $69M | $65M | - | - | ||
| Pathkey.AI Ltd is engaged in the development of its digital tools that improve clinical trials, healthcare experience for patients, deliver deep market insights from social media data, and improve the efficiency and value of the clinical research process. It invests in research and develops technologies as well as provides digital tools and insights services to healthcare, wellness, and science technology-focused clients. The group's main revenue streams are Retainer revenue and Project revenue. | $0 | -- | $52M | $52M | 2686.6x | (54.7x) | ||
| Beamtree Holdings Ltd is an Artificial intelligence (AI) health technology company. It offers software solutions like Picq, RippleDown, Risq, Ainsoff, Q Coding platform, and others across four product segments that combine into a modular software suite to assist healthcare services in transforming the quality of their data, analyzing key performance insights, and improving actionable decision support. The company's key operating product segments are: Knowledge Networks, which generate maximum revenue, Diagnostics, Clinical Decision Support, and Coding and Data Quality Assurance. Geographically, it operates in Australia, its key revenue-generating market, Europe, and the Rest of the world. | $0 | -40% | $30M | $30M | 1.5x | (132.3x) | ||
| Proteomics International Laboratories Ltd is a biological research and drug discovery company. It is a pioneering medical technology company operating at the forefront of predictive diagnostics and precision medicine. The Company specialises in proteomics-the industrial-scale study of the structure and function of proteins. Its pipeline includes Promarker, Pipeline PromarkerD, PromarkerEndo, PromarkerEso, and OxiDx. | $0 | -46% | $23M | $18M | 7.8x | (3.7x) | ||
| TALI Digital Ltd engaged in research and development, for commercialization, of medical technology projects. It is a digital health company delivering diagnostic and therapeutic solutions to improve cognitive function and behavior. | $0 | -- | $2M | $1M | 1383.3x | (2.3x) | ||
| Median | $0 | +6% | $52M | $52M | 695.6x | (29.2x) |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.